全部分类
  • Neuropeptide Y (scrambled)
Neuropeptide Y (scrambled)的可视化放大

Neuropeptide Y (scrambled)

Control peptide for neuropeptide Y (NPY)

此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

Neuropeptide Y (scrambled)的二维码
  • 库存: 现货
可选规格
  • 包装
    价格
    促销价
    数量
  • 1mg
    ¥3862.00
    3090.00
    - +
已选 0 0
金额: ¥0.00
首页 收藏
  • 货号: ajcx11040
  • CAS: N/A
  • 别名:
  • 分子式: C190H287N55O57
  • 分子量: 4253.7
  • 纯度: >98%
  • 溶解度: Soluble to 1 mg/ml in Water
  • 储存: Store at -20°C
  • 库存: 现货

Background

Scrambled Neuropeptide Y (scNPY) was similarly synthesized and contains the same amino acids as NPY, but scNPY is in a random sequence, it was used as a control in the research in NPY [1]. The sequence of scNPY is SKPQRDANREPTRYAIYDYSNPDIELHYLRPAYALG-NH2 [2].


Neuropeptide Y (NPY) is a 36-amino acid neuropeptide that exerts its activity via G-protein-coupled receptors. NPY is widely distributed in the peripheral and central nervous system. It modulates a variety of physiological processes, e.g. the central regulation of vasoconstriction, memory retention and food intake, and the regulation of circadian rhythm [2].


Scrambled NPY peptide treatment had no effect on VEGF expression in 4T1 cells. Previous treatment with scrambled NPY at concentrations ranging from 10?10 to 10?7 M made conditioned media from 4T1 cells show no difference in the number of complete endothelial networks or branch points versus control in endothelial tube formation assays [3].


In trimethyltin-treated (TMT-treated) rats, treatment with scrambled NPY for 24 h made the expression of Bdnf, NpyR, neurogenic and antiapoptotic genes comparable to that of saline-injected animals (without significant differences) [4]. In TMT-treated rats, both saline and scNPY showed no significant modulation (p> 0.05) in the expression levels of Npy1R, Npy2R and Npy5R [5].

参考文献:
[1].? Boucha?b El Bahh, Silvia Balosso, Trevor Hamilton, et al. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors. European Journal of Neuroscience, 2005, 22: 1417-1430.
[2].? Daniela Proske, Martin H?fliger, Richard M. S?ll, et al. A Y2 Receptor Mimetic Aptamer Directed against Neuropeptide Y. The Journal of Biological Chemistry, 2002, 277(13):11416-11422.
[3].? Philip J. Medeirosa and Dwayne N. Jackson. Neuropeptide Y Y5-receptor activation on breast cancer cells acts as a paracrine system that stimulates VEGF expression and secretion to promote angiogenesis. Peptides, 2013, 48:106-113.
[4].? Valentina Corvino, Elisa Marchese, Stefano Giannetti, et al. The neuroprotective and neurogenic effects of neuropeptide Y administration in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy induced by trimethyltin. J. Neurochem., 2012, 122: 415-426.
[5].? Valentina Corvino, Elisa Marchese, Maria Vittoria Podda, et al. The Neurogenic Effects of Exogenous Neuropeptide Y: Early Molecular Events and Long-lasting Effects in the Hippocampus of Trimethyltin-Treated Rats. PLOS ONE, 2014, 9(2): e88294.

没有评价数据

温馨提示 ×
商品已成功加入购物车!
购物车共 0 件商品
去购物车结算